Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | SeaStar Shares Static Ahead of Drug Trials | - | Baystreet.ca | ||
Mi | SeaStar Medical Holding Corporation: SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial | 2 | GlobeNewswire (USA) | ||
13.01. | SeaStar Medical Holding Corporation: FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome | 56 | GlobeNewswire (Europe) | Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing... ► Artikel lesen | |
13.01. | SeaStar Medical Holding Corp - 8-K, Current Report | - | SEC Filings | ||
08.01. | SeaStar Medical Holding Corporation: SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer | 1 | GlobeNewswire (USA) | ||
SEASTAR MEDICAL Aktie jetzt für 0€ handeln | |||||
26.12.24 | SeaStar Medical Holding Corp - 8-K, Current Report | 1 | SEC Filings | ||
23.12.24 | SeaStar Medical Holding Corporation: SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial | 2 | GlobeNewswire (USA) | ||
19.12.24 | SeaStar Medical Holding Corp - 8-K, Current Report | - | SEC Filings | ||
11.12.24 | SeaStar Medical Holding Corporation: SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications | 8 | GlobeNewswire (USA) | ||
03.12.24 | SeaStar Medical Holding Corporation: SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial | 1 | GlobeNewswire (USA) | ||
26.11.24 | SeaStar Medical Holding Corp - 8-K, Current Report | - | SEC Filings | ||
26.11.24 | SeaStar Medical Holding Corporation: SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024 | 2 | GlobeNewswire (USA) | ||
22.11.24 | SeaStar Medical Holding Corporation: Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares | 2 | GlobeNewswire (USA) | ||
19.11.24 | SeaStar Medical Chefmediziner erwirbt Aktien im Wert von 8.457 US-Dollar | 1 | Investing.com Deutsch | ||
15.11.24 | SeaStar Soars on Latest Tidings | 1 | Baystreet.ca | ||
15.11.24 | SeaStar Medical Holding Corporation: SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer | 95 | GlobeNewswire (Europe) | DENVER, Nov. 15, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of... ► Artikel lesen | |
13.11.24 | SeaStar Medical Holding Corporation: SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update | 156 | GlobeNewswire (Europe) | DENVER, Nov. 13, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) ("SeaStar Medical" or the "Company"), a commercial-stage medical device company developing proprietary solutions... ► Artikel lesen | |
13.11.24 | SeaStar Medical Holding Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
13.11.24 | SeaStar Medical Holding Corp - 8-K, Current Report | - | SEC Filings | ||
06.11.24 | FDA grants breakthrough status to SeaStar Medical's SCD | 1 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 36,720 | -0,22 % | DAX am Top? Fresenius, Hypoport, Kontron, Lanxess, Nemetschek, Nordex, Porsche AG, RWE, SAP ... | Am Tag der Trump-Verteidigung ist der deutsche Leitindex erneut auf ein Rekordhoch gestiegen. Bei 21.054,60 im Tagesverlauf und 20.990,31 Punkten auf Schlusskursbasis liegen jetzt die historischen Bestmarken.... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 46,650 | +0,09 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für FMC mit einem Kursziel von 52 Euro auf "Buy" belassen. Analyst Richard Felton nahm in einer am Montagabend vorliegenden... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 53,48 | -1,58 % | Siemens Healthineers: Dieser Trading-Tipp war ein Treffer ohne Gewinn! | Im Express-Service hatten wir eine Short-Trade vorgeschlagen und das war der Hinweis für Abonneten: "Charttechnisch betrachtet bewegt sich der Kurs seit Ende Juli in einer breiten Seitwärtsbewegung... ► Artikel lesen | |
GERRESHEIMER | 64,85 | +1,25 % | Unglaubliche Prognose für Montag setzt Gerresheimer AG Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
TELADOC HEALTH | 9,700 | +0,83 % | Royal Bank of Canada Boosts Teladoc Health (NYSE:TDOC) Price Target to $12.00 | ||
THERMO FISHER | 549,50 | +0,33 % | Is Thermo Fisher Stock Worth Holding on to in Your Portfolio? | ||
STRATEC | 33,300 | -1,19 % | DEUTSCHE BANK RESEARCH stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Stratec mit einem Kursziel von 39 Euro auf "Hold" belassen. Analyst Jan Koch schrieb in seinem am Montag vorliegenden Kommentar... ► Artikel lesen | |
BICO GROUP | 2,798 | -0,29 % | BD And Biosero Partner To Integrate Robotics With Flow Cytometry | WASHINGTON (dpa-AFX) - BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that they have entered into a framework... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 48,110 | -0,35 % | Eurofins Environment Testing Eaton Analytical Launches Groundbreaking Chloronitramide Anion Testing for Drinking Water | Eurofins Environment Testing Eaton Analytical, part of the Eurofins Environment Testing network of laboratories in the US and a leader in water quality analysis, has introduced a cutting-edge method... ► Artikel lesen | |
SERNOVA | 0,133 | -0,45 % | Sernova (TSE:SVA) Sets New 12-Month Low - Here's What Happened | ||
VITA 34 | 4,080 | -1,45 % | Original-Research: Vita 34 AG (von Montega AG): Vita 34 AG | Original-Research: Vita 34 AG - von Montega AG 27.11.2024 / 10:10 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung... ► Artikel lesen | |
HIMS & HERS HEALTH | 29,370 | -0,17 % | Hims & Hers CEO Andrew Dudum verkauft Aktien im Wert von 815.000 US-Dollar | ||
SYNLAB | 11,280 | 0,00 % | Schock-News für Synlab Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
DEXCOM | 84,19 | -0,46 % | Dexcom CEO says 2025 is 'shaping up to be a good year' with Stelo launch, GenAI integration | ||
BOSTON SCIENTIFIC | 97,50 | 0,00 % | Boston Scientific Corp (BSX): AI-Driven Innovation and Barclays' Bullish $111 Price Target |